- Home
- QURE vs SAFE Comparison
QURE vs SAFE Comparison
Compare QURE & SAFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QURE | SAFE |
|---|---|---|
| Founded | 1998 | 2016 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2013 | 1999 |
Fundamental Metrics
Financial Performance| Metric | QURE | SAFE |
|---|---|---|
| Price | $17.61 | $15.45 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 11 |
| Target Price | ★ $44.92 | $18.82 |
| AVG Volume (30 Days) | ★ 1.6M | 338.5K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 4.66% |
| EPS Growth | ★ 29.67 | 7.43 |
| EPS | N/A | ★ 1.59 |
| Revenue | $13,107,000.00 | ★ $385,552,000.00 |
| Revenue This Year | $126.12 | N/A |
| Revenue Next Year | $200.43 | $4.31 |
| P/E Ratio | ★ N/A | $9.56 |
| Revenue Growth | N/A | ★ 5.43 |
| 52 Week Low | $8.73 | $12.76 |
| 52 Week High | $71.50 | $17.16 |
Technical Indicators
Market Signals| Indicator | QURE | SAFE |
|---|---|---|
| Relative Strength Index (RSI) | 53.07 | 63.41 |
| Support Level | $13.47 | $15.23 |
| Resistance Level | $18.37 | $15.85 |
| Average True Range (ATR) | 1.33 | 0.41 |
| MACD | 0.27 | 0.22 |
| Stochastic Oscillator | 87.86 | 86.76 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About SAFE Safehold Inc. New
Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.